Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 20.05.2025
Julius Baer Group Ltd.
Ad hoc announcement pursuant to Art. 53 LR
Continued client momentum with solid net new money inflows of CHF 4.2 billion despite ongoing de-risking of the client book
Assets under management (AuM) at CHF 467 billion reflecting stronger Swiss franc and deconsolidation of Julius Baer Brazil
Client activity driving the increase in underlying gross m [ … ]
Tue, 20.05.2025
SMT Scharf AG
SMT Scharf AG: Longjiao Wang appointed new CEO
Hamm, May 20, 2025 – SMT Scharf AG (WKN: A3DRAE; ISIN: DE000A3DRAE2) announces that its main shareholder, Yankuang Energy Group Company Limited, has offered the company's former CEO, Mr. Jun Liu, a new position within the group following the company's Annual General Meeting today. Mr. Liu has accepte [ … ]
Tue, 20.05.2025
SAF-HOLLAND SE
Matthew Wolfe becomes new President Americas at SAF-HOLLAND
Matthew Wolfe succeeds Kent Jones who will leave SAF-HOLLAND at the end of May 2025
Bessenbach, May 20, 2025. SAF-HOLLAND SE ("SAF-HOLLAND"), one of the world's leading suppliers of trailer and truck components, has appointed Matthew Wolfe as the new President Americas with effect f [ … ]
Tue, 20.05.2025
The 29th World Gas Conference
EQS Newswire / 20/05/2025 / 16:45 CET/CEST
BEIJING, CHINA - Media OutReach Newswire - 20 May 2025 - On the morning of May 20, the 29th World Gas Conference (WGC2025) opened at the China National Convention Center in Beijing. This marks the first time in the nearly 100-year history of the World Gas Conference that the event is being held in Chi [ … ]
Tue, 20.05.2025
SAF-HOLLAND SE
SAF-HOLLAND looks back on strong operating performance in a challenging market environment – Annual General Meeting 2025 approves all agenda items
Dividend of EUR 0.85 per share resolved
New members of the Supervisory Board elected
Bessenbach, May 20, 2025. SAF-HOLLAND, one of the world's leading suppliers of trailer and truck components, dem [ … ]
Tue, 20.05.2025
Philikos BV
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
Nijmegen, the Netherlands, May 20, 2025 –Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the first patient in a Phase 1/2 clinical trial [ … ]
Tue, 20.05.2025
DocMorris AG
Frauenfeld, 20 May 2025
Press release
Ad hoc announcement pursuant to Art. 53 LR
Pelion invests in DocMorris
DocMorris AG (‘DocMorris’) was informed by Pelion S.A. (‘Pelion’), the largest company active in the healthcare sector in Poland, that Pelion has acquired a stake of 9.68% in DocMorris, calculated on the basis of the future number of sha [ … ]
Tue, 20.05.2025
Nebius Group
Nebius Group N.V. announces first quarter 2025 financial results
Amsterdam, May 20, 2025 – Nebius Group N.V. (“Nebius Group”, the “Group” or the “Company”; NASDAQ: NBIS),(1) a leading AI infrastructure company, today announced its unaudited financial results for the first quarter ended March 31, 2025.
In Q1 2025, the Group’s revenue of $ [ … ]
Tue, 20.05.2025
Funding Circle Holdings plc
Funding Circle facilitates Ninth UK public Securitisation cementing position as leading SME ABS issuer
London, 20 May 2025 – Funding Circle, the UK’s leading SME finance platform, has facilitated its latest public securitization, SBOLT 2025-1, with loans contributed by its long-term funding partner, Waterfall Asset Management (WAM).
SBOLT 2025- [ … ]
Tue, 20.05.2025
CureVac
CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
U.S. FDA clears lung cancer IND for CVHNLC, a proprietary off-the-shelf candidate targeting squamous non-small cell lung cancer (sqNCLC), with clinical study expected to begin H2 2025; Clinical Trial Application filed in Europe with decision expected [ … ]
